Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
Hisaya Kawate, Ryoichi TakayanagiDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: Bazedoxifene, a novel selective estrogen receptor modulator, has been developed to have favorable effects on bone and the lipid profile w...
Saved in:
| Main Authors: | Kawate H, Takayanagi R |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2011
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a20acec5398f45c3a04962dcb0ec23be |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eldecalcitol for the treatment of osteoporosis
by: Noguchi Y, et al.
Published: (2013) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
by: Luigi Gennari, et al.
Published: (2010) -
Selective estrogen receptor modulators: tissue specificity and clinical utility
by: Martinkovich S, et al.
Published: (2014) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009) -
Alendronate improves QOL of postmenopausal women with osteoporosis
by: Hisaya Kawate, et al.
Published: (2010)